Anchor Investment Management, LLC Gilead Sciences, Inc. Transaction History

Anchor Investment Management, LLC

$972 Billion
Q2 2024

A detailed history of Anchor Investment Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Anchor Investment Management, LLC holds 300 shares of GILD stock, worth $25,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300

Previous 300 -0.0%

Holding current value

$25,185

Previous $22 Million 6.33%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 02, 2024	BUY	$73.27 - $83.09 $21,981 - $24,927	300 New	300 $24.3 Million
Q1 2023 Jan 02, 2024	SELL	$77.31 - $88.08 $28,991 - $33,030	-375 Reduced 55.56%	300 $24.9 Million
Q4 2022 Jan 02, 2024	BUY	$62.32 - $89.47 $23,370 - $33,551	375 Added 125.0%	675 $57.9 Million
Q3 2022 Jan 02, 2024	BUY	$59.54 - $68.01 $22,327 - $25,503	375 Added 125.0%	675 $41.6 Million
Q2 2022 Jan 02, 2024	SELL	$57.72 - $65.01 $634 - $715	-11 Reduced 1.73%	625 $38.6 Million
Q1 2022 Jan 02, 2024	BUY	$57.92 - $72.58 $5,792 - $7,258	100 Added 18.66%	636 $37.8 Million
Q3 2021 Jan 02, 2024	BUY	$67.69 - $73.03 $15,974 - $17,235	236 Added 78.67%	536 $37.4 Million
Q3 2020 Jan 02, 2024	BUY	$62.1 - $78.08 $14,655 - $18,426	236 Added 78.67%	536 $33.9 Million
Q2 2020 Jan 02, 2024	BUY	$72.34 - $84.0 $3,255 - $3,780	45 Added 6.78%	709 $54.6 Million
Q1 2020 Jan 02, 2024	SELL	$62.63 - $80.22 $291,166 - $372,942	-4,649 Reduced 87.5%	664 $49.6 Million
Q4 2019 Jan 02, 2024	SELL	$61.62 - $67.78 $130,326 - $143,354	-2,115 Reduced 28.47%	5,313 $345 Million
Q3 2019 Jan 02, 2024	BUY	$62.51 - $69.0 $445,571 - $491,832	7,128 Added 2376.0%	7,428 $471 Million
Q2 2019 Jan 02, 2024	SELL	$61.87 - $69.38 $27,284 - $30,596	-441 Reduced 5.37%	7,764 $525 Million
Q1 2019 Jan 02, 2024	SELL	$62.53 - $70.05 $35,329 - $39,578	-565 Reduced 6.44%	8,205 $533 Million
Q4 2018 Jan 02, 2024	SELL	$60.54 - $79.0 $246,155 - $321,214	-4,066 Reduced 31.68%	8,770 $549 Million
Q3 2018 Jan 02, 2024	BUY	$71.28 - $78.92 $893,566 - $989,341	12,536 Added 4178.67%	12,836 $991 Million
Q2 2018 Jan 03, 2024	BUY	$64.88 - $75.68 $839,806 - $979,601	12,944 Added 4314.67%	13,244 $938 Million
Q1 2018 Jan 03, 2024	BUY	$72.84 - $88.8 $5,390 - $6,571	74 Added 0.6%	12,339 $930 Million
Q4 2017 Jan 03, 2024	SELL	$71.15 - $83.52 $14,870 - $17,455	-209 Reduced 1.68%	12,265 $879 Million
Q3 2017 Jan 03, 2024	SELL	$72.11 - $85.47 $1,586 - $1,880	-22 Reduced 0.18%	12,474 $1.01 Billion
Q2 2017 Jan 03, 2024	BUY	N/A	12,196 Added 4065.33%	12,496 $884 Million
Q1 2017 Jan 03, 2024	BUY	N/A	10,408 Added 390.84%	13,071 $888 Million
Q4 2016 Jan 03, 2024	BUY	N/A	5 Added 0.19%	2,663 $191 Million
Q3 2016 Jan 03, 2024	SELL	N/A	-3,030 Reduced 53.27%	2,658 $210 Million
Q2 2016 Jan 03, 2024	BUY	N/A	5,388 Added 1796.0%	5,688 $474 Million
Q1 2016 Jan 03, 2024	BUY	N/A	6,888	7,188 $660 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.

Account

Anchor Investment Management, LLC Gilead Sciences, Inc. Transaction History